St Cross student Peter Yeow (DPhil, Clinical Medicine) is part of a team that has recently published groundbreaking research on breast cancer in Nature. His DPhil research has uncovered a genetic vulnerability in 10% of breast cancer tumours, and the team has developed a way to exploit this in therapy to selectively kill cancer cells.
The team is led by Professor Ross Chapman and includes researchers from both Oxford and the Johns Hopkins University School of Medicine. The team's findings may have implications for other forms of cancer as well. 'This greatly expands the number of patients that stand to benefit from therapies that may emerge from our study,' Peter said.